Shenouda Maged
Relmada Therapeutics, Inc. · Chief Financial Officer
Shenouda Maged is listed in filings as Chief Financial Officer at Relmada Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 16, 2025, including purchase activity. Recent filings connect the profile to Relmada Therapeutics, Inc. (RLMD). The current snapshot covers public activity from Sep 11, 2024 to Dec 16, 2025. Reported amounts are shown as $20.9K to $71.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $21k8.2k shares | BuySep 9, 2024 | $2.55 | $5.24 | |
| $58k21.1k shares | BuySep 10, 2024 | $2.73 | $5.24 | |
| $71k24.1k shares | BuySep 11, 2024 | $2.95 | $5.24 | |
| $22k50k shares | BuyMay 16, 2025 | $0.442 | $5.24 | |
| $44k90k shares | BuyMay 19, 2025 | $0.4854 | $5.24 | |
| $31k60k shares | BuyMay 20, 2025 | $0.5237 | $5.24 | |
| $1M500k shares | BuyNov 5, 2025 | $2.20 | $5.24 |